Figure 3 | Scientific Reports

Figure 3

From: Glypican 3 as a Serum Marker for Hepatoblastoma

Figure 3

The ROC curve analysis: the diagnosis of serum glypican 3 (GPC3) and alpha-fetoprotein (AFP) for hepatoblastoma (HB) versus all controls (A) and HB versus benign hepatobiliary disease (BHD) (B). The AUROC for GPC3 and AFP was 0.63 and 0.91, respectively in A, and 0.54 and 0.87, respectively in B. AUROC indicates area under the receiver operating curve.

Back to article page